Deerfield Mgmt, L.P. 13D and 13G filings for Lumos Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-05-26 3:53 pm Sale | 2021-03-22 | 13G | Lumos Pharma, Inc. LUMO | Deerfield Mgmt, L.P. | 161,714 1.940% | -774,577![]() (-82.73%) | Filing |
2021-02-12 12:28 pm Purchase | 2020-12-31 | 13G | Lumos Pharma, Inc. LUMO | Deerfield Mgmt, L.P. | 936,291 11.280% | 936,291![]() (New Position) | Filing |